In an analysis of serum AKR1B10 levels and HCC incidence relative to fibrosis stage, severe fibrosis was found to be associated with high AKR1B10 levels in HCC and non-HCC patients [23]. The gene discussed is AKR1B10; the disease is hepatocellular carcinoma.